Biotech Fund Dumps Million: What It Signals for Investors
A major biotech-focused fund recently exited a large Nuvalent position, sparking questions about fund flows and stock...
A clear look at the stablecoins that outperformed peers this year, with insights into drivers and risk considerations for future allocations.
26,211 articlesA major biotech-focused fund recently exited a large Nuvalent position, sparking questions about fund flows and stock...
Global markets pulled back after Iran strikes sparked a heated political response. Investors weigh consequences for s...
As costs rise, Lagos’s nightlife is shifting away from table-heavy clubs toward cheaper, more inclusive raves. The tr...
In Washington, governors from both parties pressed for a sweeping review of the nation’s workforce policy amid AI-dri...
Volatility persists into March 2026, prompting a new, diversified approach to cash flow. A four-ETF plan could target...
Investors are weighing whether HOOD deserves a place in a modern portfolio. This guide helps you gauge signals, risks...
Stocks all-time highs still attract buyers as earnings momentum and AI-driven demand support another leg up. Here's t...
Portfolio manager Ben Carlson argues that avoiding big-ticket upgrades can shield households and portfolios from infl...
A Minnesota nonprofit leader was sentenced to nearly 42 years for orchestrating a $250 million fraud tied to pandemic...
A sudden 45% collapse in a SpaceX pre-IPO market on Hyperliquid sent shockwaves through crypto traders, wiping out le...
A senior executive’s $18 overage on a $2,000 dinner sets off an audit chain that reveals how small policy breaches be...
Public chatter around Kyle Cooke’s Salley Carson can reach beyond headlines and affect wallets. This guide breaks dow...